NephJC is a nephrology journal club that uses Twitter to discuss the research, guidelines, and editorials that are driving nephrology forward.

 

Regarding the situation at Twitter Bluesky

 

Celebrate a decade of NephJC

 

Upcoming Twitter chats

All scheduled chats are tentative. We may change the schedule depending on the whims of the NephJC work group

December 17th Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers for Advanced Chronic Kidney Disease: A Systematic Review and Retrospective Individual Participant–Level Meta-analysis of Clinical Trials (Ku E, et al, Ann Intern Med, 2024)


 

Twice a month (that’s aspirational, not a promise), the filtrate (Jennie Lin, Joel Topf, Jordy Cohen, Joshua Waitzman, Nayan Arora, Sophia Ambruso, and Swapnil Hiremath) sit down and recap the latest NephJC discussion. We go as deep as it takes. Give it a listen.

 

Introducing NephJC Collections

See the blog post describing this inititiative.

 
 
 
Screenshot 2019-06-30 11.49.16.png
 
Screenshot 2018-12-23 23.10.34.png
 
 
Screenshot+2018-09-10+16.56.48.png

The NephJC Twitter Journal Club Primer

The NephJC work group has produced a primer to document some of our thoughts on the practices on running a Twitter Journal Club. We think it is quite good. Take a look.

 

In the last year, NephJC has injected some statistical muscle into its editorial team (thank you Perry Wilson and Laurie Tomlinson). Then Manasi Bapat volunteered to create some cogent explainers for the various techniques that are routinely described in the methods section most of us skip over as we rush to the results. Here are the recent posts...

51106108_l.jpg

The NephJC Book Club

Every summer we blog our way through a book of medical interest and have a Twitter-based book club discussion.

 
 

Kidney Medicine